Literature DB >> 35403125

Real-time IR700 Fluorescence Imaging During Near-infrared Photoimmunotherapy Using a Clinically-approved Camera for Indocyanine Green.

Shuhei Okuyama1,2, Daiki Fujimura1,2, Fuyuki Inagaki2, Ryuhei Okada2, Yasuhiro Maruoka2, Hiroaki Wakiyama2, Takuya Kato2, Aki Furusawa2, Peter L Choyke2, Hisataka Kobayashi2.   

Abstract

Background/Aim: Near-infrared photoimmuno-therapy (NIR-PIT) is a newly approved cancer phototherapy. We aim to confirm whether a clinically approved camera for indocyanine green (ICG) could monitor IR700 fluorescence in real time during exposure to therapeutic NIR light. Materials and
Methods: An NIR camera, LIGHTVISION, designed to image ICG fluorescence, was used. A431-GFP/luc tumor-bearing mice were exposed to therapeutic NIR light and real-time fluorescence imaging (RT-FI) was obtained and measured with LIGHTVISION. Bioluminescence imaging (BLI) was performed to confirm cell death.
Results: RT-FI during NIR-PIT revealed an initial rapid loss of fluorescence, followed by a plateau which occurred at a light dose of approximately 30 J/cm 2 . Correlation between BLI and IR700 fluorescence loss showed that loss of fluorescence was associated with increased cell death.
Conclusion: The efficacy of NIR-PIT could be monitored non-invasively and in real-time using weak fluorescence at wavelengths much longer than the peak fluorescence of IR700. This technique can achieve precise light dosimetry that allows us to decide on the optimal exposure. Copyright 2021, International Institute of Anticancer Research.

Entities:  

Keywords:  ICG camera; IR700; Near infrared; photoimmunotherapy; real-time fluorescence imaging

Year:  2021        PMID: 35403125      PMCID: PMC8962761          DOI: 10.21873/cdp.10005

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  11 in total

1.  Near-Infrared Photoimmunotherapy: Photoactivatable Antibody-Drug Conjugates (ADCs).

Authors:  Hisataka Kobayashi; Gary L Griffiths; Peter L Choyke
Journal:  Bioconjug Chem       Date:  2019-09-13       Impact factor: 4.774

2.  Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors.

Authors:  Kohei Sano; Takahito Nakajima; Peter L Choyke; Hisataka Kobayashi
Journal:  ACS Nano       Date:  2012-12-18       Impact factor: 15.881

3.  Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.

Authors:  Hisataka Kobayashi; Aki Furusawa; Adrian Rosenberg; Peter L Choyke
Journal:  Int Immunol       Date:  2021-01-01       Impact factor: 4.823

4.  Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.

Authors:  Makoto Mitsunaga; Takahito Nakajima; Kohei Sano; Gabriela Kramer-Marek; Peter L Choyke; Hisataka Kobayashi
Journal:  BMC Cancer       Date:  2012-08-08       Impact factor: 4.430

5.  Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules.

Authors:  Makoto Mitsunaga; Mikako Ogawa; Nobuyuki Kosaka; Lauren T Rosenblum; Peter L Choyke; Hisataka Kobayashi
Journal:  Nat Med       Date:  2011-11-06       Impact factor: 53.440

6.  Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green.

Authors:  Fuyuki F Inagaki; Daiki Fujimura; Aki Furusawa; Ryuhei Okada; Hiroaki Wakiyama; Takuya Kato; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Pharm       Date:  2021-01-27       Impact factor: 5.364

7.  Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.

Authors:  Mikako Ogawa; Yusuke Tomita; Yuko Nakamura; Min-Jung Lee; Sunmin Lee; Saori Tomita; Tadanobu Nagaya; Kazuhide Sato; Toyohiko Yamauchi; Hidenao Iwai; Abhishek Kumar; Timothy Haystead; Hari Shroff; Peter L Choyke; Jane B Trepel; Hisataka Kobayashi
Journal:  Oncotarget       Date:  2017-02-07

8.  Real-Time Fluorescence Imaging Using Indocyanine Green to Assess Therapeutic Effects of Near-Infrared Photoimmunotherapy in Tumor Model Mice.

Authors:  Adrian Rosenberg; Daiki Fujimura; Ryuhei Okada; Aki Furusawa; Fuyuki Inagaki; Hiroaki Wakiyama; Takuya Kato; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

9.  Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy.

Authors:  Kazuhide Sato; Kanta Ando; Shuhei Okuyama; Shiho Moriguchi; Tairo Ogura; Shinichiro Totoki; Hirofumi Hanaoka; Tadanobu Nagaya; Ryohei Kokawa; Hideo Takakura; Masayuki Nishimura; Yoshinori Hasegawa; Peter L Choyke; Mikako Ogawa; Hisataka Kobayashi
Journal:  ACS Cent Sci       Date:  2018-11-06       Impact factor: 14.553

10.  Near-Infrared Photoimmunotherapy of Cancer.

Authors:  Hisataka Kobayashi; Peter L Choyke
Journal:  Acc Chem Res       Date:  2019-07-23       Impact factor: 22.384

View more
  3 in total

Review 1.  Near-Infrared Photoimmunotherapy for Thoracic Cancers: A Translational Perspective.

Authors:  Kohei Matsuoka; Mizuki Yamada; Mitsuo Sato; Kazuhide Sato
Journal:  Biomedicines       Date:  2022-07-11

2.  Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.

Authors:  Hideyuki Furumoto; Ryuhei Okada; Takuya Kato; Hiroaki Wakiyama; Fuyuki Inagaki; Hiroshi Fukushima; Shuhei Okuyama; Aki Furusawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancers (Basel)       Date:  2022-08-22       Impact factor: 6.575

3.  NIR-PIT: Will it become a standard cancer treatment?

Authors:  Aki Furusawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.